Literature DB >> 28482968

Resilience and extensively drug-resistant tuberculosis: the unlikely ally.

E Delgado1, I Monedero1, R Bhavaraju2.   

Abstract

Despite recent advances and well-known treatment options, cure rates for resistant tuberculosis (TB) cases remain extraordinarily low. We present in first person the case of a patient who suffered from TB for over 7 years, and travelled to four countries in search of a cure. This experience shows how resistance patterns worsen under poor programme conditions and illustrates many of the obstacles faced by patients to obtain appropriate care: late diagnosis, lack of experienced care capacity and drug availability, and absence of psychosocial support during toxic and lengthy regimens. In addition to new tools, patient-centred systems are needed to tackle the drug-resistant TB epidemic.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28482968     DOI: 10.5588/ijtld.16.0954

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  1 in total

1.  Mental disease, alcoholism and XDR-TB: loss to follow-up and resistance, the cost of an inadequate approach.

Authors:  Ignacio Monedero
Journal:  Public Health Action       Date:  2017-09-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.